All the news Showing 10 of 122 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Nivolumab improves outcomes in liver cancer study Liz Highleyman / 13 November 2017 Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular carcinoma (HCC) in the CheckMate ... Curing hepatitis C with DAAs linked to 71% reduction in liver cancer Liz Highleyman / 30 October 2017 People who achieved a sustained response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, ... HCV clearance lowers liver cancer risk by 70% no matter drug of choice Healio / 25 October 2017 Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers AASLD / 23 October 2017 Age, comorbidities greater impact on HCC rates than DAA therapy Healio Hepatology / 23 October 2017 Liver disease risk may be heightened by gastric acid drugs Liver Disease News from Medical News Today / 11 October 2017 Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV Michael Carter / 11 October 2017 Over a third of HIV-positive gay men develop significant liver fibrosis after an episode of acute hepatitis C virus (HCV) infection, German investigators report in the Journal of Viral Hepatitis. ... Cenicriviroc may reduce fibrosis in people with fatty liver disease Liz Highleyman / 05 October 2017 Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, was associated with a decrease in liver fibrosis in people with non-alcoholic steatosis, a type of fatty ... Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection Michael Carter / 03 October 2017 Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection, French investigators report in the ... Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection Michael Carter / 22 August 2017 Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of Clinical Infectious Diseases. The study showed ... ← Prev1...23456...13Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive